Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocad Joint Stock CofiledCriticalBiocad Joint Stock Co
Priority to ECSENADI201918367ApriorityCriticalpatent/ECSP19018367A/es
Publication of ECSP19018367ApublicationCriticalpatent/ECSP19018367A/es
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
The present invention relates to medicine. The present invention relates to development of antibodies or fragments thereof capable of specific binding to the human interleukin-6 receptor, which could be used as drugs for treating or diagnosing diseases or alleviating interleukin-6-mediated symptoms. The invention also relates to methods of producing said antibodies and a method of treating human diseases with using said antibodies.
ECSENADI201918367A2019-03-142019-03-14Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6
ECSP19018367A
(es)
Anticuerpos monoclonales que se unen específicamente a la región beta de la familia trbv-9 del receptor de células t humano, y los métodos para su uso.